The products

The AiroCide™ system is designed to reduce the levels of airborne micro-organisms, allergens, micro-organisms and VOC’s in a given area - and to maintain the low level thereafter.

This new technology, developed by NASA, is an FDA-listed Class II Medical Device, and has received the CE mark.

AiroCide™ ACS-25 unit.

AiroCide™ ACS-50 unit.

AiroCide™ ACS-100 unit.

The system was recently introduced to the UK from the USA and there is a comprehensive series of reports and data available for consideration. Studies in the UK and are already providing data to demonstrate significant reduction in allergen levels and micro organism numbers as compared pre-AiroCide™ levels.

Note: These volumes are for static air spaces where air conditioning systems are used to give multiple air changes per hour - the volumes serviced are reduced. Please contact us for more details.